| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |